30 November 2022
RUA Life Sciences Plc
("RUA Life Sciences", the "Company" or the "Group")
Investor Presentation - 12 December 2022
RUA Life Sciences plc (AIM: RUA.L), the holding company of a group of medical device businesses focused on the exploitation of the world leading long-term implantable biostable polyurethane (Elast- Eon™), is pleased to announce they will conduct an Investor Presentation which will follow the publication of the Group's interim results for the six-month period ended 30 September 2022.
The event will take place at 11.00am on Monday 12 December with Bill Brown (Chairman) and Caroline Stretton (Managing Director) presenting from the company.
The online presentation is open to all existing and potential shareholders. Questions can be submitted during the presentation to be addressed at the end.
To register for the event, please click
here
.
A recording of the presentation will be available shortly afterwards
here
.
For more information please contact:
Equity Development
Hannah Crowe / Matt Evans
020 7065 2692
|
|